Chang, Steve S., M.D.
Quick facts
Marketed products
- DDAVP · Endocrinology, Hematology
DDAVP (desmopressin) is a synthetic vasopressin analog that acts as an antidiuretic hormone (ADH) receptor agonist to increase water reabsorption in the kidneys and promote von Willebrand factor release from endothelial cells.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: